Chondro-Gide 20 years
Since the 1980s, Geistlich Pharma has been a leader in the research and production of biomaterials for bone and cartilage regeneration. As a pioneer in regenerative medicine, Geistlich has contributed significantly to the development of less invasive surgical techniques that are now possible. Now patients suffer less pain and we understand how to leverage the body’s own healing processes for enduring results.
The collagen matrix Chondro-Gide® developed by Geistlich Pharma was launched 20 years ago. It exemplifies our innovative strength as a company. To celebrate this anniversary, we have profiled some of the leading surgeons and scientists who have researched and developed the use of Chondro-Gide® for cartilage regeneration in the knee, ankle, and hip.
Read the brochure
All living systems, of all sizes — whether human beings or cells — need suitable environments to build successful communities.
When designing urban spaces, architects are guided by peoples’ needs for light, space, communication, and transportation. The development of biomaterials is subject to similar requirements at the micro level. Surfaces, spatial conditions, access, and possibilities for communication in the material determine how successfully cells settle and network.
The design and architecture of materials for regenerative processes must meet the cells’ needs. Just as we at Geistlich cultivate relationships with doctors and create opportunities for exchange, we also create environments in which cells can successfully develop and thrive.
Learn more about the Architects of Regeneration